Time: Every Thursday at 12:20pm - 1:20pm

Cancer Research Building 2, 1550 Orleans St, 1M.13
Baltimore, MD

Background Tuberculosis (TB) remains the leading cause of death among human immunodeficiency virus (HIV)–infected...

Although the proportion of global tuberculosis cases that arise from nosocomial transmission is unknown, many studies...

Editorial 

OBJECTIVE: Both isoniazid preventive therapy (IPT) and antiretroviral therapy (ART) reduce tuberculosis risk in individuals...

Widespread resistance to first-line TB drugs is a major problem that will likely only be resolved through the development of new...